Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.

This publication has 33 references indexed in Scilit:

• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
  Nature, 1993
• Human Melanoma Cells but Not Normal Melanocytes Express Vascular Endothelial Growth Factor Receptors
  Biochemical and Biophysical Research Communications, 1993
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
  Biochemical and Biophysical Research Communications, 1992
• The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
  Science, 1992
• Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix
  Biochemistry, 1992
• Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity
  Biochemical and Biophysical Research Communications, 1992
• A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations
  Cell, 1991
• Inhibition of Angiogenesis with Combination Treatments of Angiostatic Steroids and Suramin
  International Journal of Radiation Biology, 1991
• Signal transduction by receptors with tyrosine kinase activity
  Published by Elsevier ,1990
• Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family
  Biochemical and Biophysical Research Communications, 1989